The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...

Few drugs have generated as much excitement as Novo Nordisk's (NYSE: NVO) Ozempic and Wegovy. The U.S. Food and Drug Administration (FDA) approved Ozempic in December 2017 for treating type 2 diabetes ...

The Obesity Care Advocacy Network (OCAN), and more than 70 other patient advocacy organizations across the spectrum of related obesity co-morbidities, issued a statement urging the Trump ...

BMI has long been falling out of favor. When the American Medical Association urged downgrading BMI in 2023, it blamed its ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

“Effectively treating obesity requires drugs that address the root cause: addictive-like behavior toward food,” he said. “This may explain why GLP-1s have been so spectacularly successful as ...

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity ...

The Food and Drug Administration announced a new proposal Tuesday that would require food and drink manufacturers to place ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.